Known as the Wegovy pill, semaglutide tablets are taken daily rather than weekly injections
The pivotal STEP (Semaglutide Treatment Effect in People with obesity) clinical trial programme, which led to Wegovy's approval, included participants taking various concomitant medicines, including statins
Shared and dose-dependent histological and morphological changes included desquamation of enterocytes, marked mucus accumulation, hyperaemia in the lamina propria, and substantial villus shortening with mucosal thinning
have shown that riboflavin may be therapeutic for traumatic brain injury
Post-Translational Modifications (PTMs): Many therapeutic peptides undergo PTMs (e.g., amidation, glycosylation) that impact their biological activity
Four individual GLP-1 receptor agonists have now demonstrated MACE superiority in their dedicated cardiovascular outcome trials: Liraglutide: LEADER trial Semaglutide: SUSTAIN-6 and the landmark SELECT trial Dulaglutide: REWIND trial Albiglutide: HARMONY trial The SELECT trial deserves special attention because it broke entirely new ground